Exact Sciences Corporation - Common Stock (NQ:EXAS)

104.91 UNCHANGED

Last Price Updated: 4:00 PM EDT, Mar 20, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Exact Sciences Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

23 24 Next >

1 Healthcare Stock for Long-Term Investors and 2 to Be Wary Of

July 14, 2025

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But financial performance has lagged recently as players offloaded surplus COVID...

Via StockStory

Topics Stocks

Exact Sciences Announces Medicare Coverage for Oncodetect™ Molecular Residual Disease Test in Colorectal Cancer

July 09, 2025

From Exact Sciences Corp.

Via Business Wire

Forecasting The Future: 9 Analyst Projections For Exact Sciences ↗

July 08, 2025

Via Benzinga

Earnings Scheduled For May 1, 2025 ↗

May 01, 2025

Via Benzinga

Could Personalized Medicine Be Your Portfolio's Next Big Winner? Find Out ↗

June 25, 2025

BofA analysts review the promise and limits of AI in precision medicine, highlighting key players like Tempus, Guardant, and Exact Sciences.

Via Benzinga

Topics Artificial Intelligence

1 of Wall Street’s Favorite Stock with Promising Prospects and 2 to Turn Down

June 17, 2025

Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional...

Via StockStory

Topics Economy

A Look Back at Immuno-Oncology Stocks’ Q1 Earnings: Exact Sciences (NASDAQ:EXAS) Vs The Rest Of The Pack

June 11, 2025

As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the immuno-oncology industry, including Exact Sciences (NASDAQ:EXAS) and its peers.

Via StockStory

Topics Artificial Intelligence

3 Mid-Cap Stocks in the Doghouse

June 02, 2025

Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations. However, they face intense competition from...

Via StockStory

Exact Sciences Announces Expanded Clinical Validation of the Oncodetect™ Test and Molecular Residual Disease Innovation Roadmap

May 28, 2025

From Exact Sciences Corp.

Via Business Wire

Exact Sciences to Participate in June Investor Conference

May 27, 2025

From Exact Sciences Corp.

Via Business Wire

3 Low-Volatility Stocks Walking a Fine Line

May 23, 2025

Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets.

Via StockStory

Exact Sciences Highlights Innovations in Early Cancer Detection and Precision Oncology at ASCO 2025

May 22, 2025

From Exact Sciences Corp.

Via Business Wire

EXAS Q1 Earnings Call: Outperformance Driven by Commercial Execution, New Products, and Margin Expansion

May 16, 2025

Diagnostic company Exact Sciences Corporation (NASDAQ:EXAS) announced better-than-expected revenue in Q1 CY2025, with sales up 10.9% year on year to $706.8 million. The company’s full-year revenue...

Via StockStory

1 Healthcare Stock Worth Investigating and 2 to Ignore

May 16, 2025

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But speed bumps such as inventory destockings have persisted in the wake of COVID-19,...

Via StockStory

Topics Stocks

2 Brilliant Stocks to Buy With $200 and Hold for 5 Years ↗

May 14, 2025

Via The Motley Fool

Exact Sciences Earns 2025 Great Place To Work® Certification™

May 12, 2025

From Exact Sciences Corp.

Via Business Wire

Duolingo, CoreWeave And DexCom Are Among Top 10 Large-Cap Gainers Last Week (Apr 28-May 2): Are The Others In Your Portfolio? ↗

May 04, 2025

Top performing large-cap stocks in the last week: DUOL, CRWV, THC, CARR, SMMT, AUR, ANET, TT, DXCM, XPO. Most had positive financial results and raised guidance.

Via Benzinga

Exact Sciences (EXAS) Stock Trades Up, Here Is Why

May 02, 2025

Shares of diagnostic company Exact Sciences Corporation (NASDAQ:EXAS) jumped 15.2% in the morning session after the company reported strong first quarter 2025 results which beat analysts' revenue and...

Via StockStory

Trupanion Posts Better-Than-Expected Results, Joins Duolingo, DexCom, Exact Sciences And Other Big Stocks Moving Higher On Friday ↗

May 02, 2025

Via Benzinga

Cancer Diagnostic Firm Exact Sciences' CEO Says Strong Q1 Paves Way For 'Transformative' 2025, Lifts Annual Guidance ↗

May 02, 2025

Exact Sciences posted better-than-expected Q1 results and lifted its 2025 outlook, signaling confidence in growth and operational momentum.

Via Benzinga

Exact Sciences to Participate in May Investor Conference

May 02, 2025

From Exact Sciences Corp.

Via Business Wire

Why Twilio Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket ↗

May 02, 2025

Via Benzinga

Exact Sciences (NASDAQ:EXAS) Posts Better-Than-Expected Sales In Q1, Stock Soars

May 01, 2025

Diagnostic company Exact Sciences Corporation (NASDAQ:EXAS) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 10.9% year on year to $706.8 million. The company’s full-year revenue...

Via StockStory

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

May 01, 2025

Via Benzinga

Exact Sciences Hikes Its Full-Year Outlook. But There's One First-Quarter Drawback. ↗

May 01, 2025

The company hiked its sales guidance for the year, but reported steeper-than-expected first-quarter losses.

Via Investor's Business Daily

Topics Government

Exact Sciences Announces First-Quarter 2025 Results

May 01, 2025

From Exact Sciences Corp.

Via Business Wire

Exact Sciences (EXAS) Reports Q1: Everything You Need To Know Ahead Of Earnings

April 30, 2025

Diagnostic company Exact Sciences Corporation (NASDAQ:EXAS) will be reporting results tomorrow after the bell. Here’s what to look for.

Via StockStory

Topics Artificial Intelligence

Exact Sciences to Highlight Cologuard® Test Adherence and Predicted Preference Data at Digestive Disease Week (DDW) 2025

April 29, 2025

From Exact Sciences Corp.

Via Business Wire

2 Reasons to Like EXAS (and 1 Not So Much)

April 24, 2025

What a brutal six months it’s been for Exact Sciences. The stock has dropped 37.2% and now trades at $44.10, rattling many shareholders. This may have investors wondering how to approach the...

Via StockStory

Exact Sciences Launches New Test To Monitor Cancer Recurrence: Retail’s Optimistic ↗

April 22, 2025

Patients who test positive for circulating tumor DNA with the Oncodetect test during surveillance are 50 times more likely to experience cancer recurrence than those with negative results, the company...

Via Stocktwits

Topics Government

< Previous 1 2 3 4 5 6 7 8 9

...

23 24 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.